Figure 4.1-1, Structure of darapladib, a GlaxoSmithKline drug in phase III clinical trials for the treatment of atherosclerosis
Year: 2014
Type: article
Authors: Joseph M G Nagano, Ku‐Lung Hsu, Anna E Speers, Steven J. Brown, Timothy Spicer, Virneliz Fernández-Vega, J M Ferguson, Brian J. Bahnson, Benjamin F. Cravatt, Peter Hodder, Hugh Rosen
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2489640967